Kerry Group gauges probiotic potential in the age of GLP-1
As GLP-1 weight loss drugs become more common, managing side effects has emerged as key to adherence. A Kerry Group consumer perception study suggests its BC30 Probiotic may help reduce digestive discomfort linked to these medications.
Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a partnership with Juvena Therapeutics to develop new muscle-boosting drugs. The collaboration is valued at over $650 million, with the majority of this sum tied to the achievement of specific development and commercialization […]
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
The pharma giant will lose its patent protection on semaglutide, which is sold as Ozempic and Wegovy, in Canada after not paying a nominal maintenance fee years before it became a blockbuster drug for fighting diabetes and obesity, Science reported. Novo Nordisk generates billions of dollars in revenue on the drug in Canada, but patent […]
Opinion: Obesity drugs don’t just offer weight loss. They give patients agency
Powerful new obesity drugs like Wegovy and Zepbound have changed how we treat weight and chronic disease. Yet their real promise may lie in the restored belief that we can meaningfully improve our health. As David Kessler, former commissioner of the Food and Drug Administration, has poignantly described, the struggle to lose weight can feel like […]
STAT+: China, where obesity levels are low, becomes hotbed for weight loss drug trials
China has one of the lowest rates of obesity in the developed world. So why has it emerged as one of the top locations for testing the scores of new weight loss drugs cropping up every month? According to a report from clinical research organization Novotech, China is the second-most-popular country for obesity trials in […]
Research reveals how brands can innovate for the growing GLP-1 market
Given the increasing use of GLP-1s, IFF recently released a report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with food and drink.
GPs beg patients to stop asking for fat jabs as they prepare to start Mounjaro national rollout
FAMILY doctors are pleading with patients to stop asking for fat jabs as they prepare to start a Mounjaro national rollout. NHS GPs will be able to prescribe the tirzepatide drug for weight loss from next Monday. Despite soaring demand for jabs, the NHS currently only prescribes Ozempic — primarily for type 2 diabetes patients. […]
Men Are Claiming Ozempic, GLP-1 Meds Are Making Their Genitals Bigger
Some men have been claiming on social media that their penises have grown larger since they started taking GLP-1 agonist medications like Ozempic.
Advice for trying GLP-1 drugs for weight loss from a doctor who’s been there – NPR
Advice for trying GLP-1 drugs for weight loss from a doctor who’s been there NPRView Full Coverage on Google News
More research links GLP-1 drugs to potentially blinding eye diseases
submitted by /u/TechExpert11 [link] [comments]